These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 729964)

  • 1. Purification and biological activities of a mouse serum protein increased by administration of streptococcal preparation, OK-432.
    Torikai T; Itoh O; Toyoshima S; Osawa T
    Gan; 1978 Oct; 69(5):657-65. PubMed ID: 729964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of cytotoxic factor into mouse peritoneal fluid by OK-432, a streptococcal preparation.
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
    Immunol Lett; 1985; 11(2):83-8. PubMed ID: 4086064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a streptococcal preparation, OK-432, on murine hematopoietic stem cells.
    Hiraoka A; Yamagishi M; Ohkubo T; Yoshida Y; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):860-3. PubMed ID: 6977253
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of macrophage tumoricidal activity by a serum glycoprotein that increased in OK-432-treated mice.
    Torikai T; Itoh O; Satoh M; Osawa T
    Gan; 1980 Feb; 71(1):52-9. PubMed ID: 7380137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor effect of a streptococcal preparation (OK-432). 1. Positive co-relation between the anti-tumour effect and delayed type hypersensitivity reaction to OK-432 in mice.
    Makidono R; Matsuura K; Makidono A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Feb; 44(2):379-91. PubMed ID: 6477682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Basic studies on the effects of oral administration of streptococcal preparation OK-432. I. Effects of thoracic duct lymphocytes].
    Hanaue H; Kurosawa T; Nemoto A; Asagoe T; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1348-53. PubMed ID: 3501454
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative experiments with hemolytic streptococcus and its anticancer preparations (OK-431 and OK-432) for their cytolytic activity.
    Higuchi Y; Kigoshi S; Shoin S
    Jpn J Exp Med; 1980 Feb; 50(1):7-12. PubMed ID: 7382135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of biological response modifier-streptococcal preparation OK-432 on NK/K cell system of gnotobiotic miniature swine.
    Kim YB
    Prog Clin Biol Res; 1985; 181():337-41. PubMed ID: 4063011
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro effect of murine peritoneal exudate cells activated with a streptococcal preparation, OK-432, on hematopoietic stem cells.
    Hiraoka A; Yamagishi M; Ohkubo T; Yoshida Y; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):82-90. PubMed ID: 6981281
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
    Kokunai I; Shimano T; Sekimoto K; Takeda T; Kobayashi T; Yayoi E; Yamamoto A; Mori T
    J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of streptococcal preparation OK-432 on chemically-induced intestinal carcinoma in rats.
    Ichihashi H; Kuzuya H; Kondo T
    Nagoya J Med Sci; 1980 Mar; 42(3-4):49-54. PubMed ID: 7383144
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a serum glycoprotein that increased in OK-432-treated mice as hemopexin.
    Torikai T; Itoh O; Satoh M; Okumura O; Osawa T
    Gan; 1981 Feb; 72(1):92-7. PubMed ID: 7274653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions.
    Tanaka T; Kaneko Y; Haba F; Katsuta S; Tsutsui K; Tamaki S; Chen DR; Suzuki S; Ueda R; Yamamoto A
    J Clin Lab Immunol; 1989 Feb; 28(2):91-6. PubMed ID: 2787407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
    Shitara K; Ichimura O; Mitsuno T; Osawa T
    J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OK-432 stimulates primary production and activity of murine natural killer cells.
    Pollack SB
    Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiation.
    Lafreniere R; Borkenhagen K; Bryant LD; Ng E; Hayton S
    J Biol Response Mod; 1990 Feb; 9(1):53-60. PubMed ID: 2181072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of mouse peritoneal cytotoxic factor by OK-432. (3). Comparison between LPS and OK-432 as eliciting agents].
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Nishii Y; Suzuki S; Watanabe N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2419-24. PubMed ID: 3729496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.